Alexandre Wibaux

Associé

New York + 1.212.326.3829 Paris + 33.1.56.59.39.39

Contact

Partager

Classé en 2025 comme étant "Up and Coming" par Chambers & Partners, "Alexandre Wibaux is increasingly recognised in the market for his expertise in venture capital deals. He notably advises both international and domestic emerging companies, particularly in the digital sector". Il est également classé en 2025 comme étant "Next Generation Partner" par Legal500 EMEA, "Alexandre Wibaux is a star and clearly a standout partner. Great knowledge of the sector, relentless and impeccable support on corporate/commercial/fundraising/acquisition subjects".

Alexandre Wibaux intervient dans tous les domaines du private equity (capital-risque, growth equity et buy-out), des fusions-acquisitions et du droit boursier.

Il accompagne principalement des entreprises de croissance (cotées ou non) aux Etats-Unis et en France et les investisseurs qui les financent, notamment dans les secteurs du logiciel, de l'internet et des sciences de la vie, tout au long de leur développement depuis leur création jusqu'à leur cession ou leur introduction en bourse et, au-delà, dans leur vie de sociétés cotées, aux Etats-Unis et en France.

Les entreprises de croissance récemment représentées par Alexandre Wibaux comptent notamment Back Market, Bene Bono, Bibak, EcoVadis, Karos, Konvu, OpenClassrooms, Pigment et Sweep, et les investisseurs Alven Capital, Chalfen Ventures, Daphni, Earlybird, Eight Roads, Elaia, Elephant, Frst, Hedosophia, henQ, Otium, Partech Ventures, Serena Capital, Singular Capital Partners, Silver Lake, Stride.VC et Valar Ventures.

Il est dernièrement intervenu dans le cadre des cessions de CastorDoc, Doctrine, Youboox, Alkemics, Easyrecrue, Sentryo et Drivy, des acquisitions d'unifAI par Akeneo, ecotrek par EcoVadis, goFLUX par Karos, Monk par ACV Auctions, Qare par HealthHero et le groupe Optis par ANSYS, Inc, ainsi que des augmentations de capital de plusieurs sociétés cotées sur Euronext et/ou sur le Nasdaq telles que Carmat, Cellectis, Kalray ou encore Verimatrix.

Avocat aux barreaux de Paris et de New York, Alexandre est diplômé de Cornell University, de l'Université Paris II-Panthéon Assas et de la Faculty of Law (University of Oxford).

Expérience

  • Resonance leads $15 million Series A financing of DeepIPJones Day advised Resonance as lead investor in the $15 million Series A financing of DeepIP, a French startup that develops an AI assistant for drafting patents.
  • henQ participates in €25 million Series B financing of TomorroJones Day advised henQ in connection with the €25 million Series B financing of Tomorro, a French start-up engaged in the development of a contract management and negotiation platform.
  • CastorDoc sells Company to CoalesceJones Day advised CastorDoc, a French company that developed an AI-driven metadata management solution and is now known as Coalesce Catalog, in connection with the sale of the Company to Coalesce, a U.S. company specializing in data management and analysis.
  • Daphni and Serena lead €3 million seed financing of KleioJones Day advised Daphni and Serena as lead investors in the €3 million seed financing of Kleio, formerly Autodm AI, a French start-up developing a software specializing in conversational artificial intelligence for enterprises.
  • Chalfen Ventures and Stride.VC participate in €13 million Series A financing of KraaftJones Day advised Chalfen Ventures and Stride.VC in connection with the €13 million Series A financing of Kraaft, a French-based company which has developed a super construction worksite monitoring application.
  • Lucien Pagès sells Lucien Pagès group to The IndependentsJones Day advised Lucien Pagès, as seller, in the sale of the Lucien Pagès group to The Independents.
  • Chalfen Ventures leads $18 million Series A financing of Polar AnalyticsJones Day advised Chalfen Ventures as lead investor in the $18 million Series A financing of Polar Analytics, a French startup that develops software empowering consumer brands.
  • Alven Capital participates in $15 million Series A financing of Archy DentalJones Day assisted Alven Capital Partners in connection with the $15 million Series A financing of Archy Dental, an AI-powered, cloud-based platform designed specifically for dental practices by automating key processes, improving patient care, and allowing practices to run more efficiently.
  • Serena Capital participates in €2.66 million pre-seed financing of EdgeeJones Day advised Serena Capital in connection with the €2.66 million pre-seed financing of Edgee, a French company engaged in software development for edge computers.
  • Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.
  • Hedosophia leads €50 million Series A financing of NEATJones Day advised Hedosophia in connection with the €50 million Series A financing of NEAT, a French start-up operating as an embedded insurance broker.
  • Alven Capital Partners leads $14 million Series A financing of AttentionJones Day represented Alven Capital Partners as lead investor in the $14 million Series A financing of Attention, a platform that transforms customer conversations into actionable insights, offering sales teams a powerful tool to close more deals.
  • Zebra Impact Ventures leads $37 million Series B financing of AgroSpheresJones Day represented Zebra Impact Ventures as lead investor in the $37 million Series B financing of AgroSpheres Inc., a biotechnology leader in sustainable crop protection and crop health.
  • Myeloma Investment Fund invests in Nammi Therapeutics, Inc.'s Series B financingJones Day advised Myeloma Investment Fund in $1 million investment in Nammi Therapeutics, Inc.'s Series B financing.
  • Partech Partners leads €37 million Series B financing of CintooJones Day represented Partech Partners as lead investor in the €37 million Series B financing of Cintoo, the leading provider of cloud-based Reality Data management and collaboration solutions.
  • Skycatcher leads €10 million financing of SekaiJones Day advised Skycatcher in leading the €10 million financing of Sekai, a French start-up specializing in the development of mobile applications for better anime experiences.
  • Konvu raises $5 million in Series A seed financingJones Day advised Konvu, a provider of application security solutions, in connection with its $5 million seed Series A financing.
  • Silver Lake Waterman, Eurazeo, Partech Partners, Eight Roads, F-Prime, and Serena Capital participate in $54 million Series C financing of OdasevaJones Day advised Silver Lake Waterman, the lead new investor, and Eurazeo, a new investor, as well as historical investors Partech Partners, Eight Roads, F-Prime and Serena Capital in connection with the $54 million Series C financing of Odaseva, the leading enterprise data security platform for Salesforce, along with new investor Crescent Cove.
  • henQ participates in €25 million Series A financing of imaginoJones Day advised henQ in connection with the €25 million Series A financing of imagino, a revenue-first customer experience platform providing brands with clear and actionable insights through its Customer Data Platform (CDP) to enhance their marketing campaigns.
  • Daphni and 9900 Capital lead €5 million financing of KoletJones Day advised Daphni and 9900 Capital as lead investors in the €5 million seed financing of Kolet, a French startup specialized in the development and administration of websites and specific software enabling the purchase of dematerialized SIM cards (eSIM), and (ii) the implementation of internet access interfaces and local telecom networks.
    •

    November 2024 Podcast

    JONES DAY TALKS®: The Five Pillars of Protection for Later Stage VC Investors

    November 20, 2024 Firm Hosted

    Considerations For the Development and Licensing of Patent Portfolios

    September 2024 Podcast

    JONES DAY TALKS®: A Trip to the Dark Side – Venture Capital Down Rounds and Recaps

    November 20, 2024 Firm Hosted

    Considerations For the Development and Licensing of Patent Portfolios

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.